drugset / Trial / NCT06574750
Effect of a New HA Filler in Correcting Nasolabial Fold
RandomizedParallel-groupSingle-blindTreatment
Summary
The investigators aimed to evaluate the efficacy and safety of new HA filler for nasolabial fold correction
Timeline
- Start
- 2021-10-16
- Primary completion
- 2023-05-08
- Completion
- 2023-05-08
Outcome
Met primary endpoint
paper Curea demonstrated efficacy for NLF correction within the predefined noninferiority margin compared with Juvéderm. PMID 40707029 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CUREAⓇ | Other / unclassified | — | Other |
| Comparator | JuvedermⓇ | Unknown | — | Other |
Indications
No indication recorded.